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Mutagenesis of a cyclic AMP response element (CRE) within the LAT promoter of HSV-1 reduces the ability of LAT
expression to be induced in transient assays, but has only a minimal impact on reactivation of the virus in in vitro systems.
Here we show that a CRE mutation results in a significant reduction of adrenergically induced reactivation in vivo in the
rabbit eye model. Spontaneous reactivation frequencies were also reduced. In addition, we demonstrate that this mutation
has no effect on the amount of LAT expressed during latency when compared with the parent, 17syn/, and the rescuant.
These results indicate a greater effect of CRE on induced reactivation in vivo than in in vitro systems, but also suggest that
the CRE in the LAT promoter is not autonomous in conducting the reactivation signal. q 1997 Academic Press
INTRODUCTION volving cAMP. This type of mechanism would be capable
of translating stress signals from the cell to the latent
Herpes simplex viruses establish life-long latent infec- viral genome.
tions within sensory ganglia neurons and periodically Initially, the CRE at 043 was shown to be critical for
reactivate in response to environmental stimuli such as induction of LAT expression in transient assays by di-
stress (for a review see Stevens, 1989). Control of the butyryl cAMP, forskolin, nerve growth factor, or phorbol
ability to reactivate has been shown to reside within the 12-myristate 13-acetate (Leib et al., 1991). In addition,
latency associated transcription unit (LAT) of HSV-1 reactivation of wild-type virus in explant cocultivation ex-
(Block et al., 1993; Bloom et al., 1994; Hill et al., 1990; periments was found to be inhibited by cyclic AMP antag-
Sawtell and Thompson, 1992) and HSV-2 (Krause et al., onists. These data supported the hypothesis that cAMP
1995), and viruses with deletions of the LAT promoter plays an important role in HSV reactivation, and that the
show reduced reactivation in both in vitro and in vivo CRE at043 in the LAT promoter is central to this process.
models (Block et al., 1993; Bloom et al., 1994; Devi-Rao
Subsequent experiments with site-directed CRE mutants
et al., 1994; Hill et al., 1990; Krause et al., 1995; Leib et
showed that a modest, but statistically significant, reduc-
al., 1989; Perng et al., 1994). Although genetic evidence
tion in reactivation following in vitro cocultivation of
for the involvement of LAT in reactivation has been ob-
mouse trigeminal ganglia was attributable to the CRE
tained, the actual mechanism by which LAT orchestrates
mutation, suggesting that CRE plays some role in this
this process is unknown. Central to understanding this
process (Rader et al., 1993).
mechanism is identifying the trigger for initiation of the
One question raised by these studies is what impactreactivation event. Because viruses with LAT promoter
the CRE mutation would have in vivo in an induced reacti-deletions are restricted in their ability to reactivate, a
vation model. Previous studies have shown a number ofgreat deal of attention has been directed toward identi-
differences between in vivo reactivation models (infying elements within the LAT promoter that could act as
mouse, rabbit, or guinea pig) and in vitro mouse modelsswitches for this process. Notably, two cAMP-response
(Block et al., 1993; Bloom et al., 1994; Devi-Rao et al.,elements (CRE) have been identified, one at 043 to 036
1994; Hill et al., 1996). One possibility is that induced(Leib et al., 1991) and the other at 085 to 078 (Kenny et
reactivation of a CRE mutant in vivo would be more exten-al., 1994) and these elements have been proposed to
sively impaired than in vitro reactivation. Because thetrigger reactivation via a second messenger pathway in-
previous CRE mutants were constructed in a KOS strain
background, and the impact of these mutations impact
on epinephrine-induced reactivation could not be readily1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (602) 965-2272. E-mail: dcbloom@asuvm.inre.asu.edu. assessed (Hill et al., 1987), we constructed recombinant
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in strain 17syn/ and evaluated its ability to reactivate in performed daily for up to 7 days postinduction and as-
sayed on primary rabbit kidney cell monolayers for thethe rabbit eye model.
detection of infectious virus.
MATERIALS AND METHODS
Quantitation of HSV DNA and LAT transcriptsViruses, cell lines, and culture conditions
Rabbit trigeminal ganglia were snap frozen, and theHSV-1 strain 17syn/ was propagated on rabbit skin
tissue was extracted using Trizol (Life Technologies,(RS) cells. The RS cells were also employed to prepare
Gaithersburg, MD) and separated into RNA and DNAand titrate virus stocks, and for transfection experiments,
fractions according to the manufacturer’s instructions.and were maintained in MEM (Life Technologies, Gaith-
PCRs were performed in an Ericomp Thermalcycler (Sanersburg, MD) supplemented with 5% calf serum, 250 U
Diego, CA). For the detection of HSV DNA, 50-ml reactionspenicillin, 250 mg/ml streptomycin, 2.5 mg/ml amphoteri-
containing 0.5 mg of ganglionic DNA; a 0.5 mM concentra-cin B, and 292 mg/ml L-glutamine/ml.
tion of each primer (primer 1, 5* CAT CAC CGA CCC
GGA GAG GGA 3* [nt 65,866–65,886]; primer 2, 5* GGGConstruction of the recombinant 17CRE
CCA GGC GCT TGT TGG TGT 3*[nt 65,957–65,937]); 1.5
The plasmid pJGS 1 was created by site-directed muta- mM Tris (pH 8.8); 16.6 mM ammonium sulfate; 6.7 mM
genesis of the plasmid pDB23 with the oligonucleotide MgCl2 ; 0.17 mg bovine serum albumin per milliliter; a
5* GTT TTT GCA GAT CTT TCT CAG CCT T 3* (corre- 1.25 mM concentration each of dGTP, dCTP, dATP, and
sponding to the region from 118,752–118,776 nt on the dTTP; 1 mCi of [32P]dATP (6,000 Ci/mmol); and 2.5 U of
HSV genome) using the dut-/ung- selection method of Taq polymerase (Perkin–Elmer) were amplified at 94, 68,
Kunkel (1985; Zwaagstra et al., 1991). pDB23 contains a and 727, with the first cycle having a duration of 3 min
1.2-kb region encompassing the LAT promoter in pBlue- at each temperature; an additional 30 cycles were for 1
script. The oligonucleotide used for mutagenesis intro- min at each temperature. The 92-bp HSV-specific product
duced a unique BglII site into the resulting plasmid, was resolved on a 7.5% polyacrylamide gel and visual-
pJGS1, which facilitated screening. The plasmid was se- ized by autoradiography. For the detection and quantita-
quenced to confirm that the CRE mutation had been prop- tion of HSV LAT RNA, reverse transcription reactions
erly introduced and along with 17syn/ DNA was used were performed using 0.5 mg of the ganglionic RNA, 10
to cotransfect RS cells. Recombinants were screened pmol of random hexamer primers (Pharmacia); 12.5 mM
by standard techniques using Tetramethyl ammonium each of dGTP, dCTP, dTTP, and dATP (Pharmacia); 150
chloride (TMAC) hybridization (Ausubel et al., 1993) with mM KCl; 100 mM Tris, pH 8.3; 6 mM MgCl2 ; 20 mM
the oligonucleotide used for the mutagenesis as the dithiothreitol; 20 U RNasin (Promega); and 200 U of Mo-
probe. The recombinant 17CRE was further characterized MuLV reverse transcriptase (Life Technologies) in a final
by Southern blot hybridization, as well as DNA sequence reaction volume of 20 ml. Reactions were carried out for
analysis of the LAT promoter (both copies), to verify the 60 min at 377 and terminated by incubation at 1007 for
sequence of the CRE mutation. The rescue of 17CRE was 10 min. PCR was performed using 15 of each reversecreated by cotransfecting 17CRE along with the plasmid transcription reaction; a 0.5 mM concentration of each
pDB23 to restore the wild-type CRE sequences. This primer (primer 1, 5* CGG CGA CAT CCT CCC CCT AAG
transfection was also screened using TMAC hybridiza- C 3* [nt 118,888–118,908]; primer 2, 5* GAC AGA CGA
tion with the oligonucleotide GTT TTT GCT GCG TCA TCT ACG AAA CAT TCC G 3* [nt 119,036–119,015]); 67 mM
CAG CCT T (118,752–118,776 nt), which corresponds to Tris (pH 8.8); 16.6 mM ammonium sulfate; 4.0 mM MgCl2 ;the wild-type sequence. 0.17 mg bovine serum albumin per milliliter; a 1.25 mM
concentration each of dGTP, dCTP, dATP, and dTTP; 1Analysis of reactivation in the rabbit model
mCi of [32P]dATP (6,000 Ci/mmol); and 2.5 U of Taq
polymerase (Perkin–Elmer) were amplified at 94, 68, andRabbits were latently infected with HSV and were reac-
tivated using methods previously described (Bloom et al., 727, with the first cycle having a duration of 3 min at each
temperature; an additional 30 cycles were for 1 min at1994; Hill et al., 1986, 1987). Briefly, each eye of 2-kg
New Zealand White rabbits was inoculated with 1–2 1 each temperature. The 149-bp HSV-LAT-specific product
was resolved on a 5% polyacrylamide gel and visualized105 PFU of virus. The eyes were examined for corneal
epithelial lesions as evidence of acute infection and rab- by autoradiography. For all experiments, a primer pair
specific for rabbit actin (primer 1, 5* AAG ATC TGG CACbits were monitored for 40 days prior to induction. Spon-
taneous shedding was assessed by daily swabbing of CAC ACC TT 3*; primer 2, 5* CGA ACA TGA TCT GGG
TCA TC 3*) was used as an internal standard for quanti-the eyes from days 20 through 38 postinoculation.
The rabbits were induced to reactivate by transcorneal tating total DNA and RNA recovery. To determine levels
of DNA in the Trizol RNA fractions, as well as to actiontophoresis of 0.01% epinephrine (0.8 mA for 8 min)
once a day for 3 consecutive days. Eye swabs were as a control for the reverse transcription reactions, an
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FIG. 1. Construction of the virus 17CRE. Shown at the top is the HSV genome and depicted below is the location of the LAT region, including
an expanded view of the LAT promoter. The locations of a number of transcriptional elements located within the LAT promoter are indicated (Kunkel,
1985; Zwaagstra et al., 1991).
additional set of samples were mock reverse-transcribed greater and more significant reduction, suggesting that
(no RTase added). Quantitation of bands was performed the CRE mutation could impact the duration of the shed-
on a Phosphorimager using ImageQuant software (Mo- ding episodes as well. Also of interest is the observation
lecular Dynamics, Sunnyvale, CA). that the CRE mutation had an even greater effect on
spontaneous reactivation than on induced reactivation;
RESULTS AND DISCUSSION spontaneous reactivation frequencies for 17CRE were
very similar to those of 17DPst.Based on published studies with the cellular CRE rec-
DNA was extracted from 17CRE and 17CREr latentlyognition sequences, we constructed a CRE mutant in
infected rabbit trigeminal ganglia to determine whetherwhich the natural CRE sequence (CTGCGTCA) was
the reduced reactivation observed with 17CRE waschanged to CAGATCTT, a recognition sequence pre-
caused by an effect on the efficiency of the establishmentdicted to provide less than 10% binding of the CREB
of latency. However, there was no significant differenceprotein (Fig. 1). The parent strain was 17syn/ which,
in the amounts of viral DNA detected in trigeminal gan-unlike KOS, can be induced to reactivate at high frequen-
glia from rabbits latently infected with either virus (Fig.cies (Hill et al., 1987). The recombinant (17CRE) showed
2A, and Table 2). Therefore, the decrease in reactivationno alterations in growth characteristics when compared
is not the result of a replication/establishment defect.to the rescuant (17CREr) as assessed by multistep
To examine the impact of the CRE mutation on thegrowth curves on rabbit skin cells (RS) in vitro (data not
expression of LAT during latent infection in the trigeminalshown).
ganglia, Trizol RNA fractions from the same ganglia usedThe recombinant, 17CRE, and the rescuant, 17CREr,
for the DNA determinations were subjected to quantita-were analyzed for both spontaneous and induced reacti-
tive RT-PCR analysis. As shown in Fig. 2B, the amountvation phenotypes in rabbits by the ability to detect virus
of LAT detected was similar in the 17CRE virus and itsfollowing eye swabs. 17CRE showed a marked reduction
rescuant, indicating that the modification of the CRE sitein reactivation frequency following epinephrine induction
in the recombinant 17CRE does not cause a detectable(Table 1); 9 of 24 (37%) eyes and 7 of 12 (58%) 17CRE
difference in LAT expression during latency. Also, theinfected rabbits were positive for reactivation compared
amount of LAT expressed by this mutant in the rabbitto 7 of 10 (70%) eyes and 4 of 5 (80%) rabbits infected with
trigeminal ganglia during latency was similar to that pre-the rescuant. Reactivation is not reduced as dramatically,
viously quantitated in the mouse (Ackland-Berglund ethowever, as in the case of 17DPst (a LAT promoter dele-
al., 1995).tion virus) and, in fact, is somewhat intermediate (58%)
Although the total amounts of LAT and total amountsbetween the values observed for 17DPst (19%) and the
of viral DNA detected in the ganglia were the same forwild type (78%). When the total positive swabs per total
swabs are examined, however, 17CRE demonstrates a the mutant and the rescuant, we considered that there
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TABLE 1
Influence of the LAT Promoter CRE Site on HSV Reactivation
Positive rabbits/ Positive eyes/ Positive swabs/
Virus total rabbits P a total eyes P a total swabs P a
Spontaneous reactivationb
17syn/ 13/18 (72%) — 19/33 (57%) — 28/627 (4.4%) —
17DPst 3/19 (16%) 0.0356 3/37 (8%) 0.0012 4/703 (0.7%) 0.0001
17CRE 4/21 (19%) 0.0448 5/42 (12%) 0.0042 8/798 (1.0%) 0.0001
17CREr (rescuant) 3/6 (50%) 0.7171 4/12 (33%) 0.5484 12/228 (5.2%) 0.7149
Epinephrine-induced
reactivationc
17syn/ 11/14 (78%) — 19/25 (76%) — 45/175 (26%) —
17DPst 3/16 (19%) 0.0580 3/32 (9%) 0.0008 6/224 (2.7%) 0.0001
17CRE 7/12 (58%) 0.780 9/24 (37%) 0.230 13/168 (7.7%) 0.0002
17CREr (rescuant) 4/5 (80%) 1.000 7/10 (70%) 1.000 22/70 (31%) 0.5459
a P values determined by two-tailed chi-square analysis.
b Eyes swabbed from days 20 through 38 postinoculation.
c Iontophoresis once a day for 3 consecutive days. Eyes swabs were performed for 7 consecutive days.
might be a difference in the total number of neurons tional start site of the HSV LAT promoter reduces the
frequency of both spontaneous and induced reactivationexpressing LAT during latent infections with the two vi-
ruses. In situ hybridization, using a LAT probe, of every in the rabbit eye model. These results extend previous
results conducted in in vitro cocultivation systems offourth section of completely sectioned left trigeminal gan-
glia from the same rabbits analyzed for DNA and RNA mice (Rader et al., 1993) to our in vivo induction model
in rabbits. Of importance in the current study is the factby PCR showed no statistically significant differences in
the number of LAT-positive neurons per section regard- that the mutant, 17CRE seems to show a more dramatic
reduction in reactivation potential in vivo in the rabbitless of the virus (average LAT/ sites/section were 12.2
{ 3.6 for 17CRE and 7.4 { 2.8 for 17syn/). (37% of total eyes, compared to 70% for the rescue) than
in vitro in the mouse cocultivation system [73% of ganglia,These results demonstrate that mutation of the seven-
base pair CRE located at 043 relative to the transcrip- compared to 93% for the rescue (Rader et al., 1993)]. In
FIG. 2. PCR analysis of HSV DNA and LAT RNA in latently infected rabbit trigeminal ganglia. (A) Quantitation of viral DNA in latent rabbit trigeminal
ganglia by PCR. The tissue was extracted using Trizol reagent (Life Technologies, Gaithersburg, MD) and separated into RNA and DNA fractions.
The extracted DNA was subjected to PCR using a primer pair specific for the HSV polymerase gene that produces a 92-bp product. A primer pair
specific for rabbit actin (124 bp product) was used as an internal standard. (B) Quantitation of LAT RNA in latently infected rabbit trigeminal ganglia.
The extracted RNA fraction was reverse transcribed using random hexamer primers. The cDNA from the reverse transcription reactions (as well
as a duplicate mock reverse transcription set) was subjected to PCR using a primer specific for the 5* region of LAT (149-bp product) and rabbit
actin. The PCR conditions and primers used are as previously described under Materials and Methods.
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TABLE 2
Quantitation of HSV DNA Present in the Trigeminal Ganglia of Latently Infected Rabbits
Virus Rabbit HSV DNAa Rabbit actina Ratiob Average
17syn/ 1 17.9 8.08 2.20
2 22.5 19.1 1.18
1.69 { 0.51
17DPst 1 14.2 16.9 0.84
2 13.0 7.5 1.73
3 9.0 19.0 0.47
1.51 { 1.04
4 29.6 9.95 2.99
17CRE 1 23.0 21.6 1.06
2 17.6 16.4 1.07
3 20.4 18.7 1.09
0.96 { 0.17
4 16.7 26.9 0.62
17CREr 1 9.8 23.8 0.41
2 23.2 17.3 1.34
3 18.5 23.0 0.80
1.13 { 0.52
4 27.8 14.2 1.96
a HSV DNA and rabbit actin data corresponds with quantitation of the PCR fragments resulting from amplification with the samples with either a
primer pair specific for HSV DNA polymerase primer pair or for rabbit actin (as described under Materials and Methods). The values presented
are relative integrated intensities of the PCR analysis described in the legend to Fig. 2A.
b Ratio of relative intensities of HSV DNA/rabbit actin.
addition, this mutation could have an even greater effect reactivation within these neurons. Therefore, future work
may need to focus on levels of LAT expression at theon the rate of spontaneous reactivation than it does on
the rate of induced reactivation. One explanation could level of individual neurons (perhaps neurons of a specific
phenotype) rather than LAT expression at the gross tis-be that the epinephrine induction causes a number of
global responses that result in an unusually strong reacti- sue level.
vation stimulus. Although the CRE located at 043 within
the LAT promoter plays a role in reactivation, other com- ACKNOWLEDGMENTS
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